Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) - Total Liabilities
Based on the latest financial reports, Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) has total liabilities worth CN¥717.55 Million CNY (≈ $105.00 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 605016 financial resilience to evaluate the company's liquid asset resilience ratio.
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. - Total Liabilities Trend (2016–2025)
This chart illustrates how Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Shandong Bailong Chuangyuan Bio-Tech Co..
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zhejiang Hisoar Pharmaceutical Co Ltd
SHE:002099
|
China | CN¥2.17 Billion |
|
Corbion NV
AS:CRBN
|
Netherlands | €733.30 Million |
|
Nuvoco Vistas Corporation Limited
NSE:NUVOCO
|
India | Rs100.70 Billion |
|
Rizhao Port Co Ltd
SHG:600017
|
China | CN¥25.58 Billion |
|
Huapont Life Sciences Co Ltd
SHE:002004
|
China | CN¥12.29 Billion |
|
Shenzhen Xunjiexing Technology Corp. Ltd.
SHG:688655
|
China | CN¥931.96 Million |
|
Camel Group Co Ltd
SHG:601311
|
China | CN¥5.60 Billion |
|
Jiangling Motors Corp Ltd
SHE:000550
|
China | CN¥17.79 Billion |
Liability Composition Analysis (2016–2025)
This chart breaks down Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Shandong Bailong Chuangyuan Bio-Tech Co. net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.51 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.34 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2016–2025)
The table below shows the annual total liabilities of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥475.19 Million ≈ $69.54 Million |
+42.16% |
| 2024-12-31 | CN¥334.27 Million ≈ $48.91 Million |
+35.69% |
| 2023-12-31 | CN¥246.35 Million ≈ $36.05 Million |
+93.99% |
| 2022-12-31 | CN¥126.99 Million ≈ $18.58 Million |
+60.65% |
| 2021-12-31 | CN¥79.05 Million ≈ $11.57 Million |
-45.45% |
| 2020-12-31 | CN¥144.91 Million ≈ $21.20 Million |
-7.87% |
| 2019-12-31 | CN¥157.28 Million ≈ $23.01 Million |
+45.50% |
| 2018-12-31 | CN¥108.09 Million ≈ $15.82 Million |
-42.92% |
| 2017-12-31 | CN¥189.38 Million ≈ $27.71 Million |
-29.64% |
| 2016-12-31 | CN¥269.14 Million ≈ $39.38 Million |
-- |
About Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the production and sale of food and feed additives in China and internationally. The company offers dietary fibers, including polydextrose and resistant dextrin; prebiotics, such as fructo-oligosaccharide, isomalto-oligosaccharide, galacto-oligosaccharide, and xylo-oligosaccharide. It also provides starch sugars comprising allulose, maltit… Read more